Monitoring approved devices for acute ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study watches how well approved Johnson & Johnson MedTech devices work for treating acute ischemic stroke (a stroke from a blocked brain vessel). It is an observational study, so your treatment plan stays the same — the study just collects safety and effectiveness information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You (or your family member or legal guardian) must agree to the study by signing a consent form.
- A doctor must have confirmed (through imaging) that you are having an acute ischemic stroke — a stroke caused by a blocked blood vessel in the brain.
- Your doctor must have already decided to treat you with a Johnson & Johnson MedTech thrombectomy device, independent of this study.
- If you are a woman who could become pregnant, you cannot be pregnant or breastfeeding.
- You cannot be enrolled in another investigational study that could affect this study's results (with prior sponsor approval).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at which treatment approach after an ischemic stroke (a stroke caused by a blocked blood vessel) may lead to better outcomes. It may help doctors better choose treatments that improve recovery and prognosis.
This study tests a special catheter (a thin tube) designed to remove blood clots from large arteries in the brain during a stroke. The goal is to see if it is safe and effective at restoring blood flow.
This registry tracks how Medtronic's FDA-approved devices work in treating acute ischemic stroke (a type of stroke caused by a blood clot) in everyday clinical practice. Researchers collect information to understand device safety and effectiveness outside of formal clinical trials.
This trial tests a new drug, J147, for people who recently had a stroke caused by a blocked artery and have already had a procedure to reopen that artery. It aims to see if the drug can improve recovery.
This trial tests a medical device for treating acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The device is used along with standard care to try to improve recovery and reduce disability.
This study tests a rescue treatment for people having a major stroke caused by a blocked artery in the brain that also has severe narrowing. If doctors can't fully open the artery with standard clot removal, this study looks at whether additional treatments can help.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.